Details for: KETALAR
Company: ERFA CANADA 2012 INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 00224391 | KETALAR | KETAMINE (KETAMINE HYDROCHLORIDE) | 10 MG / ML | SOLUTION | INTRAMUSCULAR |
| 00224391 | KETALAR | KETAMINE (KETAMINE HYDROCHLORIDE) | 10 MG / ML | SOLUTION | INTRAVENOUS |
| 00224405 | KETALAR | KETAMINE (KETAMINE HYDROCHLORIDE) | 50 MG / ML | SOLUTION | INTRAMUSCULAR |
| 00224405 | KETALAR | KETAMINE (KETAMINE HYDROCHLORIDE) | 50 MG / ML | SOLUTION | INTRAVENOUS |
Summary Reports
Summary Safety Review - Sedative and anesthetic drugs (DIPRIVAN [propofol], KETALAR [ketamine], SEVORANE [sevoflurane], SUPRANE [desflurane], FORANE/ISOFLURANE USP [isoflurane] - Assessing the potential risk of negative effects on the development of children's brains (neurodevelopmental disorders)
Summary Safety Review - Ketamine - Assessing the Potential Risk of Liver and Bile Duct Damage
Summary Safety Review - Ketamine - Assessing the Potential Risk of Liver and Bile Duct Damage
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.